摘要
濾泡型淋巴瘤是最常見的低惡性度淋巴瘤，中位總存活期（median overall survival）大於十年。本文整理濾泡型淋巴瘤的病理、分子特性（molecular characteristics）、診斷工作所需包含的項目、及預後指標。治療上，並非所有濾泡型淋巴瘤都需接受治療。無症狀且腫瘤負擔低（low tumor burden）的病人可以先觀察。治療藥物的選擇很多，包括anti-CD20單株抗體及傳統化療藥物。
參考文獻
1. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998;16:2780-95.
2. Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood 2004;104:1258-65.
3. Federico M, Bellei M, Marcheselli L, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 2009;27:4555-62.
4. Brice P, Bastion Y, Lepage E, et al. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 1997;15:1110-17.
5. Ardeshna KM, Qian W, Smith P, et al. Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial. The Lancet Oncology 2014;15:424-35.